Cardiovascular researcher focusing on artificial intelligence, multimodal clinical data, multi-omics, and circadian biology. My research spans basic, mechanistic, and translational cardiovascular science, with particular interests in explainable AI and clinical risk prediction, atherosclerosis and vascular biology, single-cell and multi-omics approaches, translational biomarker discovery, circadian disruption, heart failure, and precision cardiovascular medicine.
Explainable machine learning, multimodal clinical data, survival analysis and decision-support tools for cardiovascular disease.
Plaque vulnerability, vascular smooth muscle cell states, single-cell genomics and molecular heterogeneity.
Transcriptomics, proteomics, metabolomics and integrated systems biology for biomarker discovery and validation.
Circadian disruption, chronobiology, vascular inflammation and precision cardiovascular medicine.
Selected publications from the complete author-controlled record. Each card links to its permanent Academic Hub paper page; enhanced Deep GEO context is shown when available.
Explainable survival-risk assessment for advanced heart failure with renal dysfunction, integrating multicenter clinical data, survival machine learning and external validation.
A publication in npj Precision Oncology (2026) titled “System biology analysis reveals circadian rhythm disorder associated with development and progression in colorectal cancer”.
A machine-learning and transcriptomic framework for quantifying atherosclerotic plaque vulnerability using bulk and single-cell data.
An integrative single-cell and bulk-transcriptomic study of vascular smooth muscle cell fate decisions and molecular heterogeneity in atherosclerosis.
A publication in ESC Heart Failure (2022) titled “Uncovering the Genetic Links of SARS-CoV-2 Infections on Heart Failure Co-Morbidity by a Systems Biology Approach”.
A publication in European Heart Journal (2025) titled “The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice”.
A publication in Med Research (2026) titled “Circadian Immunity and Vascular Inflammation in Cardiovascular Disease Chronotherapy Windows: Time for a Re-Assessment”.
A publication in JCO Precision Oncology (2024) titled “Artificial Intelligence Hybrid Survival Assessment System for Robot-Assisted Proctectomy: A Retrospective Cohort Study”.
A publication in Journal of Clinical Investigation (2026) titled “Vascular smooth muscle cell-derived KIF13B inhibits proinflammatory responses to protect against atherosclerosis”.
Plasma Olink proteomics for biomarker discovery and diagnosis in dilated cardiomyopathy with heart failure.
A mechanistic study linking idebenone-mediated cardioprotection after myocardial infarction to ROS, autophagy, ferroptosis and AMPK–mTOR signaling.